ArticleFrontiers in pharmacology2024

Real-world effectiveness of GLP-1 receptor agonist-based treatment strategies on "time in range" in patients with type 2 diabetes.

Yongru Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.